Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis Giorgiana Negrea et al, 2022, Frontiers in Pharmacology CrossRef
Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis in vivo Alina Sesarman et al, 2024, Journal of Liposome Research CrossRef
Tumor-associated macrophages favor C26 murine colon carcinoma cell proliferation in an oxidative stress-dependent manner Lavinia Luput et al, 2017, Oncology Reports CrossRef
Biologically Active Ajuga Species Extracts Modulate Supportive Processes for Cancer Cell Development Valentin-Florian Rauca et al, 2019, Frontiers in Pharmacology CrossRef
Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells Valentin-Florian Rauca et al, 2018, PLOS ONE CrossRef
Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro Laura Patras et al, 2020, International Journal of Molecular Sciences CrossRef
Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer Lucia Ruxandra Tefas et al, 2023, Journal of Liposome Research CrossRef
Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinomain vivo Laura Patras et al, 2017, Cancer Biology & Therapy CrossRef
A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy Elena De Mattia et al, 2018, Frontiers in Pharmacology CrossRef
The novel gene HA117 promotes in vitro and in vivo drug resistance in mouse colon tumor cells Y X Guo et al, 2017, Cancer Gene Therapy CrossRef
Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells Alina Sesarman et al, 2018, Pharmacological Reports CrossRef
Macrophages induce “budding” in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions Kari Trumpi et al, 2018, Oncotarget CrossRef
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition Chinmayee Sethy et al, 2021, Biomedicine & Pharmacotherapy CrossRef
Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo Lavinia Luput et al, 2020, Cancer Science CrossRef
HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition
Huachen Song et al, 2020, Drug Design, Development and Therapy CrossRef
Intensive therapy with gastropodan hemocyanins increases their antitumor properties in murine model of colon carcinoma Emiliya Stoyanova et al, 2020, International Immunopharmacology CrossRef